We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Finds Two ADHD Generics No Longer Equivalent to Brand
The item has been added to your shopping cart.
FDA Finds Two ADHD Generics No Longer Equivalent to Brand
The FDA said two generic versions of Janssen’s attention deficit hyperactivity disorder drug Concerta may not be therapeutically equivalent to the brand, a decision that could result in the products being withdrawn.